COBAS TAQMAN HBV (HIGH PURE) TEST, US-IVD 03577163190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2010-04-01 for COBAS TAQMAN HBV (HIGH PURE) TEST, US-IVD 03577163190 manufactured by Roche Molecular Systems.

Event Text Entries

[1300242] A customer site in (b)(6) reported that a false "target not detected" result was generated with a patient sample when tested with the cobas taqman hbv test for use with the high pure system, us-ivd (hps ctm hbv). The customer site indicated the discrepancy was identified when the patient sample was tested with an in-house qualitative test (same sample collection) and upon repeat testing with the hps ctm hbv test, us-ivd (new sample collection). The customer specified that the original "target not detected" result, which was generated on (b)(6) 2009, was the first time this patient was tested with the hps ctm hbv test, us-ivd. Although requested, the impact to patient treatment, if any, was not available.
Patient Sequence No: 1, Text Type: D, B5


[8539056] Quality control release testing data were reviewed and a complaint history analysis was performed. The complaint kit lot, m03237, was previously tested, on (b)(4) 2010, as part of an (b)(4) study and all results met specification. Additionally, the complaint kit met all quality control release testing specifications upon release; no failure or out of specification result was generated. Upon reviewing the complaint history for the complaint kit lot, a previous case (filed by the same customer) was detected. It appears that the same issue occurred for a different patient sample (i. E. , initial collection tnd; recollection (b)(6)). For the previous complaint case the growth curves were available and the tnd result generated was determined to be due the baseline of the normalized target curve. Unfortunately, for this current complaint case, we cannot assess the growth curves for the initial testing (tnd result) as no raw data was provided. Additionally, the customer site was unable to provide the patient specimen from the initial test run. Therefore, we cannot determine whether the current complaint case is related to the baseline normalization of the target curve or a sample specific issue with the original sample collection. Based on the information available, a device failure/malfunction could not be detected. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2243471-2010-00012
MDR Report Key1648223
Report Source05
Date Received2010-04-01
Date of Report2010-03-05
Date of Event2009-12-02
Date Mfgr Received2010-03-05
Device Manufacturer Date2009-06-19
Date Added to Maude2011-04-21
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationMEDICAL TECHNOLOGIST
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactVINCENT STAGNITTO
Manufacturer Street1080 US HWY 202S
Manufacturer CityBRANCHBURG NJ 088763733
Manufacturer CountryUS
Manufacturer Postal088763733
Manufacturer Phone9082537569
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCOBAS TAQMAN HBV (HIGH PURE) TEST, US-IVD
Generic NameHEPATITIS VIRAL B DNA DETECTION
Product CodeMKT
Date Received2010-04-01
Catalog Number03577163190
Lot NumberM03237
Device Expiration Date2010-05-31
OperatorMEDICAL TECHNOLOGIST
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerROCHE MOLECULAR SYSTEMS
Manufacturer Address1080 US HW 202S BRANCHBURG NJ 08876373 US 08876 3733


Patients

Patient NumberTreatmentOutcomeDate
10 2010-04-01

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.